SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-09-18 16:52
Tx date 2026-09-15 		$FRX
Fennec Pharmaceuticals Inc. 		Brughera, Marco
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-159,958.05
-15,545 vol
$10.29 each 		0
Filed 2026-09-18 16:50
Tx date 2026-09-15 		$FRX
Fennec Pharmaceuticals Inc. 		Brughera, Marco
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$32,799
+15,545 vol
$2.11 each 		15,545
Filed 2026-09-18 16:49
Tx date 2016-08-10 		$FRX
Fennec Pharmaceuticals Inc. 		Brughera, Marco
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2026-09-18 16:46
Tx date 2026-09-15 		$FRX
Fennec Pharmaceuticals Inc. 		Brughera, Marco
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-32,799.95
-15,545 vol
$2.11 each 		220,000
Filed 2026-09-08 11:58
Tx date 2026-09-04 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,703 vol 		241,306
Filed 2026-09-08 11:51
Tx date 2026-09-04 		$FRX
Fennec Pharmaceuticals Inc. 		Hackman, Jeffrey
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,159 vol 		66,302
Filed 2026-09-08 11:49
Tx date 2026-09-04 		$FRX
Fennec Pharmaceuticals Inc. 		Evans, Terry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+168 vol 		21,519
Filed 2026-09-08 11:48
Tx date 2026-09-04 		$FRX
Fennec Pharmaceuticals Inc. 		Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-146,160
-12,000 vol
$12.18 each 		9,519
Filed 2026-09-08 11:47
Tx date 2026-09-04 		$FRX
Fennec Pharmaceuticals Inc. 		Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+168 vol 		21,519
Filed 2026-09-08 11:45
Tx date 2026-09-04 		$FRX
Fennec Pharmaceuticals Inc. 		Cioffi, Christiana
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+156 vol 		24,644
Filed 2026-08-28 17:23
Tx date 2026-08-28 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$111,832
+21,928 vol
$5.10 each 		239,603
Filed 2026-08-28 17:22
Tx date 2026-08-28 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-111,832.80
-21,928 vol
$5.10 each 		877,402
Filed 2026-08-28 09:52
Tx date 2026-08-27 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,259,690.76
-106,844 vol
$11.79 each 		217,675
Filed 2026-08-04 11:06
Tx date 2026-08-03 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,703 vol 		324,519
Filed 2026-08-04 11:02
Tx date 2026-08-03 		$FRX
Fennec Pharmaceuticals Inc. 		Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+168 vol 		21,351
Filed 2026-08-04 11:00
Tx date 2026-08-03 		$FRX
Fennec Pharmaceuticals Inc. 		Hackman, Jeffrey
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,159 vol 		65,143
Filed 2026-08-04 10:42
Tx date 2026-08-03 		$FRX
Fennec Pharmaceuticals Inc. 		Cioffi, Christiana
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+156 vol 		24,488
Filed 2026-08-04 10:39
Tx date 2026-08-03 		$FRX
Fennec Pharmaceuticals Inc. 		Evans, Terry
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+168 vol 		21,351
Filed 2026-07-03 11:39
Tx date 2026-07-01 		$FRX
Fennec Pharmaceuticals Inc. 		Cioffi, Christiana
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+156 vol 		24,332
Filed 2026-07-03 11:35
Tx date 2026-07-01 		$FRX
Fennec Pharmaceuticals Inc. 		Hackman, Jeffrey
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,159 vol 		63,984